Cargando…

Engineering of Fc Multimers as a Protein Therapy for Autoimmune Disease

The success of Intravenous Immunoglobulin in treating autoimmune and inflammatory processes such as immune thrombocytopenia purpura and Kawasaki disease has led to renewed interest in developing recombinant molecules capable of recapitulating these therapeutic effects. The anti-inflammatory properti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fitzpatrick, Elizabeth A., Wang, Jin, Strome, S. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109252/ https://www.ncbi.nlm.nih.gov/pubmed/32269572 http://dx.doi.org/10.3389/fimmu.2020.00496

Ejemplares similares

Fc multimers effectively treat murine models of multiple sclerosis
por: Wang, Jin, et al.
Publicado: (2023)

Optimized Peptide–MHC Multimer Protocols for Detection and Isolation of Autoimmune T-Cells
por: Dolton, Garry, et al.
Publicado: (2018)

Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice
por: Jain, Ajay, et al.
Publicado: (2012)

The Complex Association of FcγRIIb With Autoimmune Susceptibility
por: Verbeek, J. Sjef, et al.
Publicado: (2019)

Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2
por: Wines, Bruce D., et al.
Publicado: (2022)

The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies
por: Monnet, Céline, et al.
Publicado: (2021)

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2
por: Wines, Bruce D., et al.
Publicado: (2023)

Editorial: Roles of Fc Receptors in Disease and Therapy
por: Ganesan, Latha P., et al.
Publicado: (2020)

Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics
por: Yang, Chunpeng, et al.
Publicado: (2018)

Editorial: Antibody Fc Engineering: Towards Better Therapeutics
por: Lei, Cheng, et al.
Publicado: (2018)

Oral Fc-Coupled Preproinsulin Achieves Systemic and Thymic Delivery Through the Neonatal Fc Receptor and Partially Delays Autoimmune Diabetes
por: Corcos, Noémie, et al.
Publicado: (2021)

Evolution of protein interfaces in multimers and fibrils
por: Zabel, W. Jeffrey, et al.
Publicado: (2019)

Engineered IgG1-Fc Molecules Define Valency Control of Cell Surface Fcγ Receptor Inhibition and Activation in Endosomes
por: Bailey, Elizabeth M., et al.
Publicado: (2021)

Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors
por: Blundell, Patricia A., et al.
Publicado: (2017)

Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds
por: Liu, Hongyan, et al.
Publicado: (2017)

Control of Cytokine Production by Human Fc Gamma Receptors: Implications for Pathogen Defense and Autoimmunity
por: Vogelpoel, Lisa T. C., et al.
Publicado: (2015)

An Engineered Human Fc variant With Exquisite Selectivity for FcγRIIIa(V158) Reveals That Ligation of FcγRIIIa Mediates Potent Antibody Dependent Cellular Phagocytosis With GM-CSF-Differentiated Macrophages
por: Kang, Tae Hyun, et al.
Publicado: (2019)

Engineered Soluble Monomeric IgG1 Fc with Significantly Decreased Non-Specific Binding
por: Wang, Chunyu, et al.
Publicado: (2017)

Antigen-dependent modulation of immune responses to antigen-Fc fusion proteins by Fc-effector functions
por: Richel, Elie, et al.
Publicado: (2023)

Importance of Fc Receptor γ-Chain ITAM Tyrosines in Neutrophil Activation and in vivo Autoimmune Arthritis
por: Németh, Tamás, et al.
Publicado: (2019)

The Neonatal Fc Receptor (FcRn): A Misnomer?
por: Pyzik, Michal, et al.
Publicado: (2019)

Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity
por: van Delft, Myrthe A. M., et al.
Publicado: (2023)

Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders
por: Ward, E. Sally, et al.
Publicado: (2022)

IgG subclass and Fc glycosylation shifts are linked to the transition from pre- to inflammatory autoimmune conditions
por: Buhre, Jana Sophia, et al.
Publicado: (2022)

Automated Analysis of Flow Cytometry Data to Reduce Inter-Lab Variation in the Detection of Major Histocompatibility Complex Multimer-Binding T Cells
por: Pedersen, Natasja Wulff, et al.
Publicado: (2017)

The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease
por: Anania, Jessica C., et al.
Publicado: (2019)

FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance
por: Caratelli, Sara, et al.
Publicado: (2017)

MHC class I multimers
por: Sun, Mei-Yi, et al.
Publicado: (2001)

Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis
por: Stockschlaeder, Marcus, et al.
Publicado: (2014)

Fc Binding by FcγRIIa Is Essential for Cellular Activation by the Anti-FcγRIIa mAbs 8.26 and 8.2
por: Wines, Bruce D., et al.
Publicado: (2021)

Peptide-MHC-Based Nanomedicines for the Treatment of Autoimmunity: Engineering, Mechanisms, and Diseases
por: Serra, Pau, et al.
Publicado: (2021)

Advances in Therapeutic Fc Engineering – Modulation of IgG-Associated Effector Functions and Serum Half-life
por: Saxena, Abhishek, et al.
Publicado: (2016)

Factor VIII-Fc Activates Natural Killer Cells via Fc-Mediated Interactions With CD16
por: Lagassé, H.A. Daniel, et al.
Publicado: (2021)

Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc
por: Dadas, Osman, et al.
Publicado: (2023)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
por: Suzuki, Takuo, et al.
Publicado: (2021)

Antibody Stabilization of Peptide–MHC Multimers Reveals Functional T Cells Bearing Extremely Low-Affinity TCRs
por: Tungatt, Katie, et al.
Publicado: (2015)

Microparticle immunocapture assay for quantitation of protein multimer amount and size
por: Gutknecht, Michael F., et al.
Publicado: (2022)

Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody
por: Kasturirangan, Srinath, et al.
Publicado: (2017)

The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases
por: Carballido, José M., et al.
Publicado: (2020)

Is Estrogen a Missing Culprit in Thyroid Eye Disease? Sex Steroid Hormone Homeostasis Is Key to Other Fibrogenic Autoimmune Diseases – Why Not This One?
por: FitzPatrick, Amy M.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pj09o0p1mjtr2dgovj6o4pulcp